IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-alpha and DTIC.

Konjevic, Gordana; Jovic, Viktor; Jurisic, Vladimir; Radulovic, Sinisa; Jelic, Svetislav; Spuzic, Ivan

Konjevic, Gordana; Jovic, Viktor; Jurisic, Vladimir; Radulovic, Sinisa; Jelic, Svetislav; Spuzic, Ivan.

Affiliation

Konjevic G; Department of Experimental Immunology, Institute for Oncology and Radiology of Serbia, Belgrade, Yugoslavia. konjevicg@ncrc.ac.yu

Clin Exp Metastasis ; 20(7): 647-55, 2003.

Article in En | MEDLINE | ID: mdl-14669796

Subject(s)

Dacarbazine/therapeutic use; Interferon-alpha/therapeutic use; Interleukin-2/pharmacology; Killer Cells, Natural/immunology; Lymphocyte Subsets/immunology; Melanoma/immunology; Melanoma/secondary; T-Lymphocytes/immunology; Tumor Necrosis Factor Receptor Superfamily, Member 7/metabolism; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Female; Humans; Lymphocyte Activation; Male; Melanoma/drug therapy; Middle Aged

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / T-Lymphocytes / Lymphocyte Subsets / Interleukin-2 / Interferon-alpha / Tumor Necrosis Factor Receptor Superfamily, Member 7 / Dacarbazine / Melanoma Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Exp Metastasis Journal subject: NEOPLASIAS Year: 2003 Document type: Article Affiliation country: Yugoslavia Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links